The Netherlands Asthma Foundation
17
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.9%
1 terminated/withdrawn out of 17 trials
91.7%
+5.2% vs industry average
29%
5 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma
Role: collaborator
Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)
Role: collaborator
Nutritional Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Muscle Atrophy
Role: collaborator
(Cost-)Effectiveness Interdisciplinary Community-based COPD Management Program (INTERCOM)
Role: collaborator
Weight-reduction Intervention in Asthmatic Children With Overweight/Obesity
Role: collaborator
Early Diagnosis of Asthma in Young Children
Role: collaborator
Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
Role: collaborator
Predicting the Course of Chronic Obstructive Pulmonary Disease (COPD) in Primary Care
Role: collaborator
COPD on Primary Care Treatment (COOPT)
Role: collaborator
Smoking Cessation in Patients With COPD (SMOCC) in General Practice
Role: collaborator
Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics
Role: lead
The Additional Value of Noninvasive Ventilation Next to Rehabilitation in Hypercapnic COPD Patients
Role: collaborator
Evaluation of Spirometry Expert Support in General Practice
Role: collaborator
Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.
Role: lead
Modification Of Disease Outcome In COPD
Role: collaborator
Towards Restoring the Physiological Inhibition of Airway Narrowing in Asthma
Role: collaborator
Asthma Management Project University Leiden
Role: collaborator
All 17 trials loaded